| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JALZ.2016.08.003 |
| P698 | PubMed publication ID | 27693183 |
| P50 | author | Michelle K Lupton | Q57010958 |
| Magda N. Tsolaki | Q57073392 | ||
| Luke Whiley | Q58826085 | ||
| Bruno Vellas | Q66877204 | ||
| Simon Lovestone | Q30582986 | ||
| Iwona Kłoszewska | Q38633661 | ||
| Patrizia Mecocci | Q46713839 | ||
| Petroula Proitsi | Q47504060 | ||
| Latha Velayudhan | Q51895272 | ||
| P2093 | author name string | Andrew Simmons | |
| John F Powell | |||
| Richard J B Dobson | |||
| Min Kim | |||
| Martina Sattlecker | |||
| Cristina Legido-Quigley | |||
| Hillka Soininen | |||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 140-151 | |
| P577 | publication date | 2016-09-28 | |
| P1433 | published in | Alzheimer's and Dementia | Q15750965 |
| P1476 | title | Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis | |
| P478 | volume | 13 |
| Q52609763 | A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations. |
| Q51760901 | A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. |
| Q30235315 | A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling |
| Q92345820 | A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort |
| Q100387519 | A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia |
| Q33563660 | APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease. |
| Q49464422 | Application of Metabolomics in Alzheimer's Disease |
| Q40444820 | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease |
| Q51764769 | Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts. |
| Q41687826 | Blood-based metabolic signatures in Alzheimer's disease |
| Q99635766 | Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease |
| Q101564177 | Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease |
| Q90598631 | Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation |
| Q59125187 | Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort |
| Q92994454 | Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence |
| Q89879977 | Lipids and Alzheimer's Disease |
| Q62492840 | Machine learning studies on major brain diseases: 5-year trends of 2014-2018 |
| Q92924243 | Male Infertility: Shining a Light on Lipids and Lipid-Modulating Enzymes in the Male Germline |
| Q89484972 | Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease |
| Q41196957 | Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study |
| Q41583852 | Neuroprotective Actions of Dietary Choline. |
| Q91750984 | Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development |
| Q90644662 | PathBank: a comprehensive pathway database for model organisms |
| Q88042926 | Plasma Lipidomics of Healthy Japanese Adults Reveals Gender- and Age-Related Differences |
| Q51246561 | Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease. |
| Q90089057 | Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology |
| Q104076099 | Systems biology approaches to study lipidomes in health and disease |
| Q88774089 | Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging |
| Q91867935 | The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment |
| Q48393490 | The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease. |
| Q92639913 | The relationship between blood lipids and plasma amyloid beta is depend on blood pressure: a population-based cross-sectional study |
| Q49917617 | The serum metabolomics signature of Type 2 Diabetes is obscured in Alzheimer's Disease |
Search more.